drugset / Trial / NCT00817011
Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Non-randomizedParallel-groupTriple-blindTreatment
Summary
The Purpose of this study is to predict antidepressant response in advance using pharmacogenomics and peripheral biological markers in depressed patients.
Timeline
- Start
- 2006-04
- Primary completion
- 2016-12
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupropion | Small molecule | — | — |
| Subject | Citalopram | Small molecule | — | — |
| Comparator | Duloxetine | Small molecule | — | — |
| Subject | Fluoxetine | Small molecule | — | — |
| Comparator | Mirtazapine | Other / unclassified | — | — |
| Comparator | Nortriptyline | Small molecule | — | — |
| Subject | Paroxetine | Small molecule | — | — |
| Subject | Sertraline | Small molecule | — | — |
| Comparator | Trazodone | Small molecule | — | — |
| Comparator | Venlafaxine | Small molecule | — | — |